• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 疫苗接种对新冠后心脏并发症的影响。

Impact of COVID-19 vaccination in post-COVID cardiac complications.

机构信息

Instituto Cardiovascular Lezica, Buenos Aires, Argentina.

Instituto Cardiovascular Lezica, Buenos Aires, Argentina.

出版信息

Vaccine. 2023 Feb 17;41(8):1524-1528. doi: 10.1016/j.vaccine.2023.01.052. Epub 2023 Jan 27.

DOI:10.1016/j.vaccine.2023.01.052
PMID:36725436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9885297/
Abstract

BACKGROUND

After the acute infection, COVID-19 can produce cardiac complications as well as long-COVID persistent symptoms. Although vaccination against COVID-19 represented a clear reduction in both mortality and ICU admissions, there is very little information on whether this was accompanied by a decrease in the prevalence of post-COVID cardiac complications. The aim of this study was to analyze the relationship between COVID-19 vaccination and the prevalence of post-COVID cardiac injury assessed by echocardiogram, and long-COVID persistent cardiac symptoms.

METHODS

All patients who consulted for post-COVID evaluation 14 days after discharge from acute illness were included. Patients with heart disease were excluded. The relationship between complete vaccination scheme (at least two doses applied with 14 days or more since the last dose) and pathological echocardiographic findings, as well as the relationship of vaccination with persistent long-COVID symptoms, were evaluated by multivariate analysis, adjusting for age, sex and clinical variables that would have shown significant differences in univariate analysis.

RESULTS

From 1883 patients, 1070 patients (56.8%) suffered acute COVID-19 without a complete vaccination scheme. Vaccination was associated with lower prevalence of cardiac injury (1.35% versus 4.11%, adjusted OR 0.33; 95% CI 0.17-0.65, p=0.01). In addition, vaccinated group had a lower prevalence of persistent long-COVID symptoms compared to unvaccinated patients (10.7% versus 18.3%, adjusted OR 0.52; 95% CI 0.40-0.69, p<0.001).

CONCLUSION

Vaccination against COVID-19 was associated with lower post-COVID cardiac complications and symptoms, reinforcing the importance of fully vaccinating the population.

摘要

背景

急性感染后,COVID-19 可引发心脏并发症和长 COVID 持续症状。尽管 COVID-19 疫苗接种显著降低了死亡率和 ICU 住院率,但关于 COVID-19 疫苗接种是否会降低长 COVID 后心脏并发症的发生率,目前知之甚少。本研究旨在分析 COVID-19 疫苗接种与超声心动图评估的长 COVID 后心脏损伤和长 COVID 持续心脏症状的相关性。

方法

纳入急性疾病出院后 14 天内因长 COVID 就诊的所有患者。排除患有心脏病的患者。通过多变量分析,调整年龄、性别和单变量分析中显示有显著差异的临床变量,评估完全疫苗接种方案(至少接种两剂,最后一剂后 14 天或以上)与病理性超声心动图结果之间的关系,以及疫苗接种与持续长 COVID 症状之间的关系。

结果

在 1883 名患者中,有 1070 名(56.8%)患者患有未经完全疫苗接种方案治疗的急性 COVID-19。疫苗接种与较低的心脏损伤发生率相关(1.35%比 4.11%,调整 OR 0.33;95%CI 0.17-0.65,p=0.01)。此外,与未接种疫苗的患者相比,接种疫苗的患者长 COVID 持续症状的发生率较低(10.7%比 18.3%,调整 OR 0.52;95%CI 0.40-0.69,p<0.001)。

结论

COVID-19 疫苗接种与较低的长 COVID 后心脏并发症和症状相关,这强化了为人群全面接种疫苗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcc/9885297/98c8430e5b49/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcc/9885297/98c8430e5b49/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dcc/9885297/98c8430e5b49/gr1_lrg.jpg

相似文献

1
Impact of COVID-19 vaccination in post-COVID cardiac complications.COVID-19 疫苗接种对新冠后心脏并发症的影响。
Vaccine. 2023 Feb 17;41(8):1524-1528. doi: 10.1016/j.vaccine.2023.01.052. Epub 2023 Jan 27.
2
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.接种疫苗和未接种疫苗患者 1 年后的 COVID-19 后综合征与体液反应相关性。
Clin Microbiol Infect. 2022 Aug;28(8):1140-1148. doi: 10.1016/j.cmi.2022.03.016. Epub 2022 Mar 23.
3
Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.青少年接种新冠病毒mRNA疫苗后心肌炎的心脏磁共振成像表现
AJR Am J Roentgenol. 2022 Apr;218(4):651-657. doi: 10.2214/AJR.21.26853. Epub 2021 Oct 27.
4
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.COVID-19 疫苗接种对长新冠综合征的保护作用:系统评价和荟萃分析。
Vaccine. 2023 Mar 10;41(11):1783-1790. doi: 10.1016/j.vaccine.2023.02.008. Epub 2023 Feb 8.
5
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.新冠感染后 6 个月持续的 COVID-19 症状和接种疫苗在 SARS-CoV-2 感染前后的作用。
JAMA Netw Open. 2023 Jan 3;6(1):e2251360. doi: 10.1001/jamanetworkopen.2022.51360.
6
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.SARS-CoV-2 感染和 mRNA COVID-19 疫苗接种后的心脏并发症 - PCORnet,美国,2021 年 1 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1.
7
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.灭活新冠病毒疫苗对 B.1.617.2(德尔塔)变异株感染患者肺损伤的影响。
Ann Clin Microbiol Antimicrob. 2023 Mar 21;22(1):22. doi: 10.1186/s12941-023-00569-z.
8
Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.接种疫苗后 SARS-CoV-2 感染的 6 个月后遗症:10024 例突破感染的回顾性队列研究。
Brain Behav Immun. 2022 Jul;103:154-162. doi: 10.1016/j.bbi.2022.04.013. Epub 2022 Apr 18.
9
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种与心肌炎或心肌心包炎:基于人群的队列研究
BMJ. 2021 Dec 16;375:e068665. doi: 10.1136/bmj-2021-068665.
10
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.

引用本文的文献

1
Long-term outcomes of patients with pre-existing coronary artery disease after SARS-CoV-2 infection.感染新型冠状病毒2(SARS-CoV-2)后原有冠状动脉疾病患者的长期预后
EBioMedicine. 2025 Jun;116:105778. doi: 10.1016/j.ebiom.2025.105778. Epub 2025 May 28.
2
Factors Associated with Post-COVID Cardiac Conditions and Potential Prognostic Factors: A Systematic Review.与新冠后心脏疾病相关的因素及潜在预后因素:一项系统综述
Life (Basel). 2025 Feb 28;15(3):388. doi: 10.3390/life15030388.
3
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review.

本文引用的文献

1
Long-term cardiac pathology in individuals with mild initial COVID-19 illness.轻症 COVID-19 患者的长期心脏病理学变化。
Nat Med. 2022 Oct;28(10):2117-2123. doi: 10.1038/s41591-022-02000-0. Epub 2022 Sep 5.
2
COVID-19 Vaccine and Long COVID: A Scoping Review.新冠疫苗与新冠长期症状:一项范围综述
Life (Basel). 2022 Jul 16;12(7):1066. doi: 10.3390/life12071066.
3
The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network.
影响新冠病毒疫苗接种对成人新冠后状况影响的因素:一项系统文献综述
Hum Vaccin Immunother. 2025 Dec;21(1):2474772. doi: 10.1080/21645515.2025.2474772. Epub 2025 Mar 13.
4
Predictors of Cardiovascular Symptoms Among Long COVID Patients: Data from the Polish Long COVID Cardiovascular (PoLoCOV-CVD) Study.新冠长期症状患者心血管症状的预测因素:来自波兰新冠长期心血管(PoLoCOV-CVD)研究的数据。
J Clin Med. 2025 Feb 2;14(3):956. doi: 10.3390/jcm14030956.
5
Pathogenic mechanisms of cardiovascular damage in COVID-19.COVID-19 中心血管损伤的发病机制。
Mol Med. 2024 Jun 19;30(1):92. doi: 10.1186/s10020-024-00855-2.
6
Identifying patterns of reported findings on long-term cardiac complications of COVID-19: a systematic review and meta-analysis.识别关于 COVID-19 长期心脏并发症的报告发现模式:系统评价和荟萃分析。
BMC Med. 2023 Nov 28;21(1):468. doi: 10.1186/s12916-023-03162-5.
7
COVID Vaccination as a Strategy for Cardiovascular Disease Prevention.COVID 疫苗接种作为预防心血管疾病的策略。
Curr Cardiol Rep. 2023 Oct;25(10):1327-1335. doi: 10.1007/s11886-023-01950-2. Epub 2023 Sep 9.
2019冠状病毒病(COVID-19)疫苗接种对COVID-19急性后遗症的保护作用:一项来自大型国家健康研究网络的多中心研究。
Open Forum Infect Dis. 2022 May 7;9(7):ofac228. doi: 10.1093/ofid/ofac228. eCollection 2022 Jul.
4
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study.SARS-CoV-2 疫苗接种对 COVID-19 后后遗症(PASC)的影响:一项前瞻性队列研究。
Vaccine. 2022 Jul 30;40(32):4424-4431. doi: 10.1016/j.vaccine.2022.05.090. Epub 2022 Jun 7.
5
Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021.2021 年 1 月至 11 月,爱沙尼亚、爱尔兰、卢森堡和斯洛伐克的监测数据分析显示,接种疫苗的 COVID-19 病例的重症结局风险降低。
Euro Surveill. 2022 Feb;27(7). doi: 10.2807/1560-7917.ES.2022.27.7.2200060.
6
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.长新冠:聚焦心血管的 COVID-19 后急性后遗症。
Eur Heart J. 2022 Mar 14;43(11):1157-1172. doi: 10.1093/eurheartj/ehac031.
7
Long-term cardiovascular outcomes of COVID-19.COVID-19 长期心血管后果。
Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3. Epub 2022 Feb 7.
8
Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study.新型冠状病毒2型疫苗接种对新冠后遗症症状的影响:全国性VAXILONG研究结果
Vaccines (Basel). 2021 Dec 30;10(1):46. doi: 10.3390/vaccines10010046.
9
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.与 COVID-19 疫苗接种或 SARS-CoV-2 感染相关的心肌炎、心包炎和心律失常风险。
Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.
10
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.新型冠状病毒2疫苗在真实世界研究中的有效性和安全性:一项系统评价与荟萃分析
Infect Dis Poverty. 2021 Nov 14;10(1):132. doi: 10.1186/s40249-021-00915-3.